{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:57:35Z","timestamp":1773701855444,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.amjmed.2020.03.037","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T02:12:09Z","timestamp":1587435129000},"page":"1065-1073.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Longer Predialysis ACEi\/ARB Utilization Is Associated With Reduced Postdialysis Mortality"],"prefix":"10.1016","volume":"133","author":[{"given":"Elvira O.","family":"Gosmanova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9665-330X","authenticated-orcid":false,"given":"Miklos Z.","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0649-6089","authenticated-orcid":false,"given":"Praveen","family":"Potukuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-8772","authenticated-orcid":false,"given":"Abduzhappar","family":"Gaipov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-0024","authenticated-orcid":false,"given":"Barry M.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1325-4870","authenticated-orcid":false,"given":"Fridtjof","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elani","family":"Streja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2020.03.037_bib0001","unstructured":"Centers for Disease Control and Preventon. chronic kidney disease in the United States. Available at: http:\/\/www.cdc.gov\/ckd. Accessed January 6, 2019."},{"issue":"7","key":"10.1016\/j.amjmed.2020.03.037_bib0002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cardfail.2006.05.008","article-title":"Effects of angiotensin-converting enzyme inhibitors in systolic heart failure patients with chronic kidney disease: a propensity score analysis","volume":"12","author":"Ahmed","year":"2006","journal-title":"J Card Fail"},{"issue":"6","key":"10.1016\/j.amjmed.2020.03.037_bib0003","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ahj.2007.03.017","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease","volume":"153","author":"Berger","year":"2007","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.037_bib0004","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0085-2538(15)50905-8","article-title":"Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: a national Veterans Administration study","volume":"68","author":"Gibney","year":"2005","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.amjmed.2020.03.037_bib0005","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","article-title":"Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study","volume":"109","author":"McAlister","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.amjmed.2020.03.037_bib0006","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jacc.2013.10.050","article-title":"Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease","volume":"63","author":"Molnar","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.037_bib0007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000086050","article-title":"Diabetic nephropathy, percutaneous coronary interventions, and blockade of the renin-angiotensin system","volume":"104","author":"Reinecke","year":"2005","journal-title":"Cardiology"},{"issue":"24","key":"10.1016\/j.amjmed.2020.03.037_bib0008","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1161\/01.CIR.0000149806.01354.BF","article-title":"Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study","volume":"110","author":"Tokmakova","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjmed.2020.03.037_bib0009","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.amjmed.2020.03.037_bib0010","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/j.1523-1755.2000.00381.x","article-title":"ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure","volume":"58","author":"Bakris","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.037_bib0011","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11154-016-9384-x","article-title":"Updates in hyperkalemia: outcomes and therapeutic strategies","volume":"18","author":"Kovesdy","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"10.1016\/j.amjmed.2020.03.037_bib0012","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2215\/CJN.07821109","article-title":"Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors","volume":"5","author":"Weir","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3 Suppl 1","key":"10.1016\/j.amjmed.2020.03.037_bib0013","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US renal data system 2016 annual data report: epidemiology of kidney disease in the United States","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2020.03.037_bib0014","first-page":"372","article-title":"KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1016\/j.amjmed.2020.03.037_bib0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"vidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.amjmed.2020.03.037_bib0016","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2215\/CJN.10611015","article-title":"Antihypertensive medication use in older patients transitioning from chronic kidney disease to end-stage renal disease on dialysis","volume":"11","author":"Chang","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.amjmed.2020.03.037_bib0017","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamainternmed.2013.12700","article-title":"Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia","volume":"174","author":"Hsu","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.amjmed.2020.03.037_bib0018","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1093\/ndt\/gfp511","article-title":"The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease","volume":"25","author":"Ahmed","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.037_bib0019","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.ajkd.2016.12.020","article-title":"Blood pressure before initiation of maintenance dialysis and subsequent mortality","volume":"70","author":"Sumida","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2020.03.037_bib0020","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/ndt\/gfw220","article-title":"Association between vascular access creation and deceleratio of estimated glomerular filtration rate declne in late-stage chronic kidney disease patients transitioning to end-stage renal disease","volume":"32","author":"Sumida","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.amjmed.2020.03.037_bib0021","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.2311","article-title":"Association of continuation of statin therapy initiated before transition to chronic dialysis therapy with mortality after dialysis initiation","volume":"1","author":"Streja","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.amjmed.2020.03.037_bib0022","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/ndt\/gfy178","article-title":"Acute kidney injury following coronary revascularization procedures in patients with advanced CKD","volume":"34","author":"Gaipov","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.amjmed.2020.03.037_bib0023","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjmed.2020.03.037_bib0024","series-title":"VIReC Resource Guide: VA Corporate Data Warehouse","year":"2012"},{"key":"10.1016\/j.amjmed.2020.03.037_bib0025","series-title":"VIReC Research User Guide: Veterans Health Administration Decision Support System Clinical National Data Extracts","year":"2009"},{"issue":"9","key":"10.1016\/j.amjmed.2020.03.037_bib0026","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2020.03.037_bib0027","series-title":"VIReC Research User Guide: VHA Pharmacy Prescription Data.","year":"2008"},{"key":"10.1016\/j.amjmed.2020.03.037_bib0028","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"issue":"16","key":"10.1016\/j.amjmed.2020.03.037_bib0029","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.109.853648","article-title":"Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure","volume":"120","author":"Anand","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjmed.2020.03.037_bib0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.amjmed.2020.03.037_bib0031","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1681\/ASN.2007020256","article-title":"Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study","volume":"18","author":"Perkovic","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.037_bib0032","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12882-017-0753-9","article-title":"Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients","volume":"18","author":"Vejakama","year":"2017","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.amjmed.2020.03.037_bib0033","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000441684","article-title":"Mineral metabolites, angiotensin ii inhibition and outcomes in advanced chronic kidney disease","volume":"42","author":"Jovanovich","year":"2015","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.037_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170874","article-title":"The impact of renin-angiotensin system blockade on renal outcomes and mortality in pre-dialysis patients with advanced chronic kidney disease","volume":"12","author":"Oh","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.amjmed.2020.03.037_bib0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gft515","article-title":"Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"10.1016\/j.amjmed.2020.03.037_bib0036","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjmed.2020.03.037_bib0037","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.ajkd.2008.04.031","article-title":"Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial","volume":"52","author":"Suzuki","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.amjmed.2020.03.037_bib0038","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/ndt\/gfl293","article-title":"Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis\u2013a randomized study","volume":"21","author":"Takahashi","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.amjmed.2020.03.037_bib0039","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","article-title":"Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies","volume":"70","author":"Zannad","year":"2006","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.amjmed.2020.03.037_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012690","article-title":"Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study","volume":"6","author":"Mansfield","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.amjmed.2020.03.037_bib0041","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000447068","article-title":"Should we stop angiotensin converting enzyme inhibitors\/angiotensin receptor blockers in advanced kidney disease?","volume":"133","author":"Ahmed","year":"2016","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.amjmed.2020.03.037_bib0042","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/j.ajkd.2018.06.010","article-title":"Use of renin-angiotensin system blockade in advanced CKD: An NKF-KDOQI controversies report","volume":"72","author":"Weir","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2020.03.037_bib0043","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ndt\/gfv346","article-title":"Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial","volume":"31","author":"Bhandari","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.amjmed.2020.03.037_bib0044","first-page":"c8","article-title":"Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race","volume":"120","author":"Hayes","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"6","key":"10.1016\/j.amjmed.2020.03.037_bib0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000437151","article-title":"Serum potassium, end-stage renal disease and mortality in chronic kidney disease","volume":"41","author":"Nakhoul","year":"2015","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1016\/j.amjmed.2020.03.037_bib0046","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jamainternmed.2018.4749","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury","volume":"178","author":"Brar","year":"2018","journal-title":"JAMA Intern Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320303430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320303430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:29:27Z","timestamp":1762079367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934320303430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0002934320303430"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.03.037","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longer Predialysis ACEi\/ARB Utilization Is Associated With Reduced Postdialysis Mortality","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}